Anti-inflammatory effects of a p38 mitogen-activated protein kinase inhibitor during human endotoxemia.
about
Science review: mechanisms of impaired adrenal function in sepsis and molecular actions of glucocorticoidsMitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.Activated microglia decrease histone acetylation and Nrf2-inducible anti-oxidant defence in astrocytes: restoring effects of inhibitors of HDACs, p38 MAPK and GSK3βInhibition of p38 MAPK suppresses inflammatory cytokine induction by etoposide, 5-fluorouracil, and doxorubicin without affecting tumoricidal activityBIRB796, the inhibitor of p38 mitogen-activated protein kinase, enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cellsActivation of p38MAPK contributes to expanded polyglutamine-induced cytotoxicity.Of microbes and meals: the health consequences of dietary endotoxemia.Macrophage migration inhibitory factor regulates interleukin-6 production by facilitating nuclear factor-kappa B activation during Vibrio vulnificus infectionA novel chromone derivative with anti-inflammatory property via inhibition of ROS-dependent activation of TRAF6-ASK1-p38 pathwayLPS- and LTA-induced expression of IL-6 and TNF-α in neonatal and adult blood: role of MAPKs and NF-κB.Regulation of microglia activity by glaucocalyxin-A: attenuation of lipopolysaccharide-stimulated neuroinflammation through NF-κB and p38 MAPK signaling pathwaysMitogen-activated protein kinase kinase 3 is a pivotal pathway regulating p38 activation in inflammatory arthritis.Identification of p38β as a therapeutic target for the treatment of Sézary syndrome.Increased endoplasmic reticulum stress response is involved in clopidogrel-induced apoptosis of gastric epithelial cellsThe anti-inflammatory carbazole, LCY-2-CHO, inhibits lipopolysaccharide-induced inflammatory mediator expression through inhibition of the p38 mitogen-activated protein kinase signaling pathway in macrophages.Review article: mitogen-activated protein kinases in chronic intestinal inflammation - targeting ancient pathways to treat modern diseases.Inhibition of Toll-like receptor 9 attenuates sepsis-induced mortality through suppressing excessive inflammatory response.Macrophage glucocorticoid receptors regulate Toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinaseEnhanced TNF-alpha-induced apoptosis in Fanconi anemia type C-deficient cells is dependent on apoptosis signal-regulating kinase 1.SB203580, a p38 inhibitor, improved cardiac function but worsened lung injury and survival during Escherichia coli pneumonia in mice.The p38 mitogen-activated protein kinase signaling cascade in CD4 T cells.Mitogen activated protein kinase inhibitors: where are we now and where are we going?Drug insight: novel small molecules and drugs for immunosuppression.A potent and selective p38 inhibitor protects against bone damage in murine collagen-induced arthritis: a comparison with neutralization of mouse TNFalpha.From therapy to experimental model: a hundred years of endotoxin administration to human subjects.Rapamycin enhances LPS induction of tissue factor and tumor necrosis factor-alpha expression in macrophages by reducing IL-10 expression.Anti-inflammatory effect of longan seed extract in carrageenan stimulated Sprague-Dawley rats.New approaches to the treatment of inflammatory disease : focus on small-molecule inhibitors of signal transduction pathways.Neutrophil mobilization and clearance in the bone marrow.Flavonoids Identified from Korean Scutellaria baicalensis Georgi Inhibit Inflammatory Signaling by Suppressing Activation of NF- κ B and MAPK in RAW 264.7 Cells.SD0006: a potent, selective and orally available inhibitor of p38 kinase.Signal transduction pathways involved in brain death-induced renal injury.Does muscle-derived interleukin-6 mediate some of the beneficial effects of exercise on cancer treatment-related fatigue?Mitogen activated protein kinases: a role in inflammatory bowel disease?MAPK signal transduction underlying brain inflammation and gliosis as therapeutic target."Go upstream, young man": lessons learned from the p38 saga.Targeting signaling pathways with small molecules to treat autoimmune disorders.Emerging drugs for chronic obstructive pulmonary disease.Interleukin 1alpha (IL-1alpha) induced activation of p38 mitogen-activated protein kinase inhibits glucocorticoid receptor function.Mitogen-activated kinase pathway activation in epidermal lamellae in the acute stages of carbohydrate overload laminitis models and the effect of regional deep hypothermia on signalling pathways.
P2860
Q24800806-3B666077-F668-4EDE-A673-F7FF554C8C11Q28296128-C5BB0717-CE8B-4E2E-9BF0-869ABC5C844CQ28383951-A4679A6B-1A28-4A48-9544-09E472787050Q28472865-694B2723-5953-4429-8B68-9D9F120B61E3Q28485188-BEEA3040-2F36-493F-98C0-F5C2A25BFDF2Q33332140-DE4F0E47-0DB0-4B70-B7F9-74F584243FD1Q33713662-C024FAE0-2C5E-4E99-93C9-EDA695CCE6D5Q33715838-6DD0222B-0503-4F42-8A4C-639B6CEB8712Q34312376-5CFC7221-3BD1-42FA-B0E7-7FE1CD4B30AAQ34501184-02A404B6-C6C4-47A6-AF5A-921C8ED267A5Q34581033-0E5EB4D8-0BEB-4AA2-BFCE-70EF31AB9DE3Q34600313-3031A830-AB7A-4A40-9867-8F2ACCBB6B0DQ34899213-C73E8435-24D9-4C25-BFE2-F5C018DCFBDAQ34994652-81059404-8A59-4F7A-BD34-DEE7FCBB40FFQ35046269-96C1B57C-4730-483F-B799-391ED4ECC957Q35171811-08602F18-C87F-4A67-9860-5467478A5117Q35630065-92C88869-9F1C-426B-9DA2-E459A1B087EEQ35828722-E7E29556-26F4-44B7-B0E0-CC82D11B3EE7Q35848170-3337CB81-C1A1-4818-8C73-59D9DE351591Q36076268-38F56894-6BCF-4138-9EB7-1A6AFB919C0FQ36423252-177E39C3-4036-43E0-95C7-EB66FF999795Q36622407-07DEDE7D-9DB3-48B2-AB92-5EF3E291A75CQ36636145-72307939-087A-4203-ABB7-DEFC6D2B4AA9Q36735853-115FB8A4-1BD3-4198-B4FF-4EE73CD13098Q36994694-D813189E-BB18-467B-A4F8-7BD8FEB17883Q37236661-8B0DBFBA-55B6-472D-B2DC-B695A50C6BD0Q37306941-53FF1D03-7C34-4DBD-A3FE-D3E4DC8DC3F5Q37319544-EFC31B0E-12FE-4EA1-B997-B0F8EA3EC0A2Q37364116-0E172A97-0785-410E-87F9-29B29208C444Q37379898-D8958292-C035-4870-92FE-10A6BC2B2885Q37466941-39992566-096D-4A8F-B26B-5BA52B0F5410Q37473453-1CF50564-E2B1-4075-B779-C2FFF92BA482Q37590990-0C054B6C-6A7D-4222-96FB-82F7A2079C01Q37605958-0F1E4B58-22D4-4B74-ABA8-49DB1505A3D4Q37640015-1A65B3A8-7D87-4C78-8393-855A85ED08F0Q37649076-6A28F246-9E6D-4211-81C6-EC4A4992C3C7Q37755216-96DF0551-28CB-491B-8A21-FF2DD0B575EBQ37984088-4A27C9AC-8039-4C24-85B3-52A7F467FED8Q38346438-8C4BA95D-C23E-45D7-885F-468490C32BD5Q38385178-7D721956-C911-4A4C-A182-3561A0BCB008
P2860
Anti-inflammatory effects of a p38 mitogen-activated protein kinase inhibitor during human endotoxemia.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Anti-inflammatory effects of a ...... itor during human endotoxemia.
@en
type
label
Anti-inflammatory effects of a ...... itor during human endotoxemia.
@en
prefLabel
Anti-inflammatory effects of a ...... itor during human endotoxemia.
@en
P2093
P1476
Anti-inflammatory effects of a ...... itor during human endotoxemia.
@en
P2093
Abhya Gupta
Bernt van den Blink
C Erik Hack
Carina L Bos
Chan-Loi Yong
Dariusz P Olszyna
Jeffrey Madwed
Judith Branger
Sander J H van Deventer
Sebastiaan Weijer
P304
P356
10.4049/JIMMUNOL.168.8.4070
P407
P577
2002-04-01T00:00:00Z